宫颈癌早期筛查的临床应用价值  

Clinical application value of cervical cancer early screening

作　　者：向明 

机构地区：[1]广州市番禺疗养院,广东广州511490

出　　处：《中国当代医药》2010年第15期185-186,共2页China Modern Medicine

摘　　要：目的:探讨液基细胞薄层涂片(TCT)+阴道镜法与巴氏宫颈涂片法(PAP)对宫颈癌及癌前病变早期筛查的临床价值。方法:本院2006年8月～2009年7月对560例宫颈癌的高危人群应用液基细胞薄层涂片+阴道镜法及巴氏宫颈涂片法进行检查,并以病理组织学检查作为参照标准。结果:与巴氏宫颈防癌涂片法的诊断结果相比较,液基细胞薄层涂片+阴道镜法与病理组织学检出符合率高。结论:液基细胞薄层涂片+阴道镜法在宫颈癌的早期诊断中价值优于巴氏宫颈涂片法,值得临床推广应用。Objective：To research into the clinical value of ThinPrep Cytology Test（TCT） ＋ colposcope method and Papanicolaou（PAP） methods on the screening of early cervical cancer and precancerous lesion.Methods：From August 2006 to July 2009, our hospital used ThinPrep Cytology Test（TCT） ＋colposcope method and Papanicolaou（PAP） methods to examine 560 cases of cervical cancer high-risk group, and also used pathological examination as referential standards.Results：Compared with the diagnosis results of the Papanicolaou method, the positive rate of ThinPrep Cytology Test（TCT） ＋ colposcope method plus pathological examination was higher.Conclusion：The application value of ThinPrep Cytology Test（TCT） ＋ colposcope method in early diagnosis of cervical cancer is higher than that of Papanicolaou method, and is worthy of clinical popularization and application.

关 键 词：液基细胞薄层涂片 巴氏宫颈涂片 宫颈癌 癌前病变 诊断 

分 类 号：R737.33[医药卫生—肿瘤]